StreetAlpha.app
Home › Stocks › VTRS

Viatris Inc (VTRS)

Healthcare
Members
LATEST PRICE

Viatris makes and sells generic, branded and newer medicines for patients around the world. VTRS reports earnings on Thu, Nov 5, 2026. Analyst consensus is Buy, based on the latest ratings from 6 firms (3 buy, 3 hold, 0 sell). In the past 30 days there were 9 dark pool prints.

Prices, price targets and earnings estimates for VTRS are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is VTRS in one of our four AI portfolios? Sign in free to see
Next report
Nov 5
2026 · Time not announced
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Buy
Based on 6 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
6firms
3 Buy3 Hold0 Sell
Each firm's latest rating on VTRS in the past 90 days
Average 12-month target
Price targets for VTRSThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
Piper SandlerTarget raised
Oct 26Hold
JP MorganMaintained
Oct 21Hold
UBSMaintained
Oct 5Hold
OppenheimerInitiated
Sep 23Buy
Piper SandlerMaintained
Sep 16Hold
DateFirmActionRatingPrice target
Oct 26Piper SandlerTarget raisedHold
Oct 21JP MorganMaintainedHold
Oct 5UBSMaintainedHold
Sep 23OppenheimerInitiatedBuy
Sep 16Piper SandlerMaintainedHold
Loading…

Whale Options Flow

90D

No whale options trades in VTRS in the last 90 days.

Loading…

Dark Pool

30D
Prints
9
Notional
Largest print
Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VTRS is in one of them and how their past VTRS trades turned out.

VTRS in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered VTRS in an article yet. Here's the latest on the wider market.

VTRS Congress Trades

All congress trades →
Trades, 12 months
1
Buys
1
100%
Sells
0
0%
People
1
Last filed Dec 15
Who traded VTRS · since 2020
Latest 5 filings of 40
$1K – $15KTraded Nov 18, 2025Filed Dec 15, 2025
$1K – $15KTraded Apr 8, 2025Filed May 8, 2025
Gilbert CisnerosSell (partial)
$1K – $15KTraded Mar 31, 2025Filed Apr 7, 2025
$1K – $15KTraded Mar 30, 2025Filed Apr 6, 2025
$1K – $15KTraded Feb 25, 2025Filed Mar 28, 2025
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CABuy$1K – $15KNov 18, 2025Dec 15, 202527 d
Rob BresnahanR · PASell$1K – $15KApr 8, 2025May 8, 202530 d
Gilbert CisnerosD · CASell (partial)$1K – $15KMar 31, 2025Apr 7, 20257 d
Gilbert CisnerosD · CASell$1K – $15KMar 30, 2025Apr 6, 20257 d
Rob BresnahanR · PABuy$1K – $15KFeb 25, 2025Mar 28, 202531 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Viatris

Viatris is a healthcare company based in Canonsburg, Pennsylvania, that makes and sells medicines for patients around the world. Its portfolio includes generic medicines, including complex products, familiar branded medicines, and newer medicines it is developing. It runs manufacturing, packaging and distribution sites worldwide and serves patients and other customers in many countries.

Headquarters
Canonsburg, PA
Founded
2020